Synergistic effect of interleukin-6 promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women

American Journal of Reproductive Immunology

Volumn 56, Issue 4, 2006, Pages 267-274

  Kitawaki, Jo ^a   Kiyomizu, Miyo ^a   Obayashi, Hiroshi ^b   Ohta, Mitsuhiro ^c   Ishihara, Hiroaki ^a   Hasegawa, Goji ^a   Nakamura, Naoto ^a   Yoshikawa, Toshikazu ^a   Honjo, Hideo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Institute of Bio Response Informatics   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Endometriosis; Gene gene interaction; Inter cellular adhesion molecule 1; Interleukin 6; Polymorphism

Indexed keywords

CYTOSINE; GLUTAMIC ACID; GUANINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LYSINE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

ADULT; AMINO ACID SUBSTITUTION; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; JAPAN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RISK;

EID: 33747886426     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00426.x     Document Type: Article

References (38)

1. Simpson JL, Elias S, Malinak LR, Buttram VC Jr: Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980;137: 327-331.
2. Magnus P: The familial risk of endometriosis. Acta Obstet Gynecol Scand 1993;72: 560-564.
3. Kennedy S, Mardon H, Barlow D: Familial endometriosis. J Assist Reprod Genet 1995;12: 32-34.
4. Treloar SA, O'Connor DT, O'Connor VM, Martin NG: Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 1999;71: 701-710.
5. Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V, Dawson G, Mackay IJ, Weeks DE, Bennett ST, Carey A, Ewen-White KR, Duffy DL, O'Connor DT, Barlow DH, Martin NG, Kennedy SH: Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005;77: 365-376.
6. Berkkanoglu M, Arici A: Immunology and endometriosis. Am J Reprod Immunol 2003;50: 48-59.
7. Wu MY, Ho HN: The role of cytokines in endometriosis. Am J Reprod Immunol 49;285, 2003.
8. Kitawaki J, Obayashi H, Ohta M, Kado N, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, Honjo H: Genetic contribution of the interleukin-10 promoter polymorphism in endometriosis susceptibility. Am J Reprod Immunol 2002;47: 12-18.
9. Teramoto M, Kitawaki J, Koshiba H, Kitaoka Y, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Matsushita M, Maruya E, Saji H, Ohta M, Honjo H: Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol 2004;51: 352-357.
10. Kitawaki J, Koshiba H, Kitaoka Y, Teramoto M, Hasegawa G, Nakamura N, Yoshikawa T, Ohta M, Obayashi H, Honjo H: Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis. Hum Reprod 2004;19: 1765-1769.
11. Kitawaki J, Obayashi H, Kado N, Ishihara H, Koshiba H, Maruya E, Saji H, Ohta M, Hasegawa G, Nakamura N, Yoshikawa T, Honjo H: Association of HLA class I and class II alleles with susceptibility to endometriosis. Hum Immunol 2002;63: 1033-1038.
12. Rier SE, Zarmakoupis PN, Hu X, Becker JL: Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: Correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 1995;80: 1431-1437.
13. Harada T, Yoshioka H, Yoshida S, Iwabe T, Onohara Y, Tanikawa M, Terakawa N: Increased interleukin-6 levels in peritoneal fluid Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997;176: 593-597.
14. D'Hooghe TM, Xiao L, Hill JA: Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis. Arch Gynecol Obstet 2001;265: 40-44.
15. Bedaiwy MA, Falcone T: Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod 2002;17: 426-431.
16. Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275: 18138-18144.
17. Lee MK, Park AJ, Kim DH: Tumor necrosis factor-alpha and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosis. Fertil Steril 2002;77: 1304-1305.
18. Wieser F, Fabjani G, Tempfer C, Schneeberger C, Sator M, Huber J, Wenzl R: Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing. J Soc Gynecol Investig 2003;10: 32-36.
19. Bhanoori M, Babu KA, Deenadayal M, Kennedy S, Shivaji S: The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women. J Soc Gynecol Investig 2005;12: 365-369.
20. Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M: Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999;1: 115-119.
21. Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T: Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 2002;19: 1000-1005.
22. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M: A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001;46: 267-272.
23. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE: Interleukin-6 gene -174g>c and -572 g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21: 1453-1463.
24. Nishimura M, Maeda M, Yasunaga J, Kawakami H, Kaji R, Adachi A, Uchiyama T, Matsuoka M: Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy. Hum Immunol 63;697, 2002.
25. Vigano P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M: Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4: 1150-1156.
26. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A: Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6: 315-325.
27. Lee SJ, Drabik K, Van Wagoner NJ, Lee S, Choi C, Dong Y, Benveniste EN: ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J Immunol 2000;165: 4658-4666.
28. Vigano P, Vercellini P, Di Blasio AM, Colombo A, Candiani GB, Vignali M: Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril 1991;56: 894-899.
29. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56: 45-51.
30. Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY: Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod 1995;10: 2671-2675.
31. Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW: Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 1994;21: 473-477.
32. Vigano P, Infantino M, Lattuada D, Lauletta R, Ponti E, Somigliana E, Vignali M, DiBlasio AM: Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis. Mol Hum Reprod 2003;9: 47-52.
33. Matsuzawa J, Sugimura K, Matsuda Y, Takazoe M, Ishizuka K, Mochizuki T, Seki SS, Yoneyama O, Bannnai H, Suzuki K, Honma T, Asakura H: Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population. Gut 2003;52: 75-78.
34. Yamashita M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T: Association study of endometriosis and intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in a Japanese population. J Soc Gynecol Investig 2005;12: 267-271.
35. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67: 817-821.
36. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: Genotype-phenotype association study in Japanese cases. Am J Med Genet 2002;114: 436-439.
37. Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P: Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003;34: 881-885.
38. Combarros O, Infante J, Llorca J, Pena N, Fernandez-Viadero C, Berciano J: Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk. J Neurol 2005;252: 485-487.